Versant Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Versant Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.2K	Buy	1,636 +191	+13%	+$6.53K	0.01%	1241
2026 Q1	$47.8K	Hold	1,445	–	–	﹤0.01%	1264
2025 Q4	$66.9K	Hold	1,445	–	–	0.01%	941
2025 Q3	$50.6K	Sell	1,445 -105	-7%	-$3.65K	0.01%	1033
2025 Q2	$45.8K	Buy	+1,550	New	+$44.2K	0.01%	1025
2022 Q2	–	Sell	-12	Closed	–	–	1468
2022 Q1	$0	Hold	12	–	–	﹤0.01%	1479
2021 Q4	$0	Hold	12	–	–	﹤0.01%	1456
2021 Q3	$0	Hold	12	–	–	﹤0.01%	1466
2021 Q2	$0	Hold	12	–	–	﹤0.01%	1465
2021 Q1	$0	Hold	12	–	–	﹤0.01%	1531
2020 Q4	$0	Hold	12	–	–	﹤0.01%	1362
2020 Q3	$0	Hold	12	–	–	﹤0.01%	1324
2020 Q2	$0	Hold	12	–	–	﹤0.01%	1327
2020 Q1	$0	Buy	+12	New	+$248	﹤0.01%	1357

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Versant Capital Management's COLL Position: Q2 2026 in Review

Versant Capital Management increased its Collegium Pharmaceutical (COLL) stake by 13% in Q2 2026, buying an estimated $6.53K and bringing the position to 1,636 shares worth $59.2K. The position accounts for 0.01% of the portfolio, ranked #1241.

Versant Capital Management first reported a position in COLL in Q1 2020 and has held it in 14 quarters since. The position peaked at $66.9K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Versant Capital Management held 1,636 shares of Collegium Pharmaceutical worth $59.2K as of Q2 2026.
Versant Capital Management bought 191 Collegium Pharmaceutical shares in Q2 2026, an estimated $6.53K.
Collegium Pharmaceutical made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #1241 holding.
Versant Capital Management first reported a position in Collegium Pharmaceutical in Q1 2020 and has held it in 14 quarters since.
Versant Capital Management's Collegium Pharmaceutical position peaked at $66.9K in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.